Video Message to Investors and Demo
LexaGene’s CEO Dr. Jack Regan delivers a video message to investors and demonstrates workflow of the MiQLab™ System. Watch video.
MiQLab™ overview video
LexaGene’s MiQLab™ automated genetic analyzer delivers sample-to-answer insight with speed and sensitivity at the point-of-need to markets in need of reference laboratory quality data in less time.
Interview: LexaGene placement in hospital testing lab
To expand on the news of LexaGene’s placement in a major US hospital laboratory for COVID-19 testing, Dr. Jack Regan spoke to an investment program about the latest on company plans. Watch video.
News recap of new hire and LexaGene testing
LexaGene CEO and Founder Dr. Jack Regan talks with Proactive Investors about the importance of making another key hire to further the goal of a successful commercial launch of the LX Analyzer – and also discusses how LexaGene’s powerful and fast detection of COVID-19 and other respiratory pathogens compares to new testing.
Coronavirus news recap
LexaGene CEO and Founder Dr. Jack Regan explains the threat of the current coronavirus outbreak and recaps LexaGene’s latest news describing the company’s role in preventing the spread of pathogens like coronavirus.
LexaGene featured on CBS Boston 4
LexaGene was featured on CBS Boston 4 WBZ during the news reporting of the EEE virus outbreak in Massachusetts
and other states.
Interview on EEE Testing
LexaGene CEO Dr. Jack Regan speaks to Proactive Investors explaining what LexaGene is doing to help respond to the rising threat of EEE Virus in Massachusetts and other states. Watch video.
LexaGene discusses ASL beta testing for Human Clinical
LexaGene CEO Dr. Jack Regan discusses beta testing client Assurance Scientific Laboratories (ASL) and their plans to use the LX Analyzer prototype in human clinical diagnostics. Watch video.
LexaGene discusses FDA AR Isolate Bank
LexaGene discusses recent approval by CDC and FDA Antibiotic Resistance Isolate Bank to receive samples for testing. Watch video.
Interview on filing three additional patents
LexaGene CEO Dr. Jack Regan discusses the recent filing of three additional patents and plans for the company. Watch video.
Beta Testimonial Video
Vets at Massachusetts Veterinary Referral Hospital describe how LexaGene’s beta prototype has excited them and given them a view of the future: rapid, in-clinic diagnostics that improve confidence in diagnosis, clinic workflow and patient outcome.
Interview on Antibiotic Resistance Panel
Dr. Jack Regan discusses LexaGene’s development of an antibiotic resistance panel to detect antibiotic resistance in pathogens in just one hour.
12